Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert B Carter is Director at Quest Diagnostics. OQRO lists 5 transactions filed with the SEC under this name, the latest on Oct 23, 2026, each linked to the official Form 4.
Director
Disclosures on record
5
Companies involved
1
Robert B Carter bought shares on the open market in 2012, and has not bought since 2012 across 2 companies. Sales in 18 of the 21 years since 2006.
Robert B Carter reported 5 open-market purchases and 80 sales since 2006; purchases in 2012.
| Year | Bought | Sold |
|---|---|---|
| 2024 | — | $4.71M1×1 trade |
| 2023 | — | $4.74M1×1 trade |
| 2022 | — | $5.6M2×2 trades |
| 2021 | — | $4.86M1×1 trade |
| 2020 | — | $5.62M3×3 trades |
| 2019 | — | $4.06M2×2 trades |
| 2017 | — | $12.8M4×4 trades |
| 2016 | — | $8.38M4×4 trades |
| 2015 | — | $141×1 trade |
| 2014 | — | $4.36M2×2 trades |
| 2013 | — | $4.29M8×8 trades |
| 2012 | $100K5×5 trades | $4.12M6×6 trades |
| 2011 | — | $1.88M1×1 trade |
| 2010 | — | $2.74M3×3 trades |
| 2009 | — | $1.58M8×8 trades |
| 2008 | — | $979K11×11 trades |
| 2007 | — | $1.54M18×18 trades |
| 2006 | — | $1.84M4×4 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Quest DiagnosticsDGX
5 disclosures · Feb 2026 – Oct 2026
Oct 21, 202610disclosed Oct 23
DetailsOfficial recordJul 22, 202611disclosed Jul 27
DetailsOfficial recordMay 20, 20261,142disclosed May 21
DetailsOfficial recordApr 20, 20267disclosed Apr 24
DetailsOfficial recordJan 28, 20266disclosed Feb 20
DetailsOfficial recordAs of the latest filing on , Robert B Carter reported holding 3,874 shares of Quest Diagnostics (DGX), worth about $1M at the last close of $259 (Nov 19, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Quest Diagnostics DGX | 3,874 | 3,874 direct | $259 | $1M | Oct 21, 2026 |
Is this Robert B Carter’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Robert B Carter reported 0 open-market purchases and 76 sales here, 2006 to 2024.
Robert B Carter reported 5 open-market purchases and 4 sales here, 2008 to 2015.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Oct 21, 2026, Robert B Carter reported holding 3,874 shares of Quest Diagnostics (DGX). At the last close of $259 on Nov 19, 2026, that is about $1M. This is the stake disclosed in filings, not a net worth.
No public filing gives Robert B Carter's net worth. What SEC Form 4 shows is the stock stake: 3,874 shares of Quest Diagnostics (DGX), about $1M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Robert B Carter bought shares on the open market in 2012, and has not bought since 2012 across 2 companies. Sales in 18 of the 21 years since 2006.
In SEC filings since 2006: the latest open-market purchase is from 2012; the latest open-market sale is from 2024.
2 companies: FedEx (FDX, 2006–2024), First Horizon (FHN, 2008–2015).